Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program

被引:29
作者
Charoenwoodhipong, Prae [1 ]
Harlow, Sioban D. [1 ]
Marder, Wendy [1 ]
Hassett, Afton L. [1 ]
McCune, W. Joseph [1 ]
Gordon, Caroline [2 ]
Helmick, Charles G. [3 ]
Barbour, Kamil E. [3 ]
Wang, Lu [1 ]
Mancuso, Peter [1 ]
Somers, Emily C. [1 ]
Zick, Suzanna M. [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
DISEASE-ACTIVITY; SLEEP; SUPPLEMENTATION; FIBROMYALGIA; VALIDATION; PROTECTINS; RESOLVINS; CRITERIA; QUALITY; TRIAL;
D O I
10.1002/acr.23925
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine associations between dietary intake of omega-3 (n-3; generally antiinflammatory) and omega-6 (n-6; generally proinflammatory) fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE). Methods This study was based on the population-based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n-3 and n-6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient-reported outcomes included self-reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n-3 and n-6, as well as the n-6:n-3 ratio, and patient-reported outcomes. Results Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean +/- SD age was 52.9 +/- 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6;P= 0.013) with each unit increase of the n-6:n-3 ratio. Both lupus activity and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1-gram/1,000 kcal increase of n-3 fatty acids (SLAQ regression coefficient beta = -0.8 [95% CI -1.6, 0.0];P= 0.055; PROMIS sleep beta = -1.1 [95% CI -2.0, -0.2];P= 0.017). Higher n-3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. Conclusion This population-based study suggests that higher dietary intake of n-3 fatty acids and lower n-6:n-3 ratios are favorably associated with patient-reported outcomes in SLE, particularly self-reported lupus activity and sleep quality.
引用
收藏
页码:874 / 881
页数:8
相关论文
共 49 条
[1]   Alterations in Circulating Fatty Acid Composition in Patients with Systemic Lupus Erythematosus: A Pilot Study [J].
Aghdassi, Elaheh ;
Ma, David W. L. ;
Morrison, Stacey ;
Hillyer, Lynn M. ;
Clarke, Shannon ;
Gladman, Dafna D. ;
Urowitz, Murray B. ;
Fortin, Paul R. .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2011, 35 (02) :198-208
[2]   Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus [J].
Arriens, Cristina ;
Hynan, Linda S. ;
Lerman, Robert H. ;
Karp, David R. ;
Mohan, Chandra .
NUTRITION JOURNAL, 2015, 14
[3]   Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by Docosahexaenoic Acid Consumption [J].
Bates, Melissa A. ;
Brandenberger, Christina ;
Langohr, Ingeborg I. ;
Kumagai, Kazuyoshi ;
Lock, Adam L. ;
Harkema, Jack R. ;
Holian, Andrij ;
Pestka, James J. .
PLOS ONE, 2016, 11 (08)
[4]   Fish Oil N-3 Fatty Acids Increase Adiponectin and Decrease Leptin Levels in Patients with Systemic Lupus Erythematosus [J].
Batisti Lozovoy, Marcell Alysson ;
Colado Simao, Andrea Name ;
Morimoto, Helena Kaminami ;
Scavuzzi, Bruna Miglioranza ;
Mayumi Iriyoda, Tathiana Veiga ;
Vissoci Reiche, Edna Maria ;
Cecchini, Rubens ;
Dichi, Isaias .
MARINE DRUGS, 2015, 13 (02) :1071-1083
[5]   Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus [J].
Bello, Kayode J. ;
Fang, Hong ;
Fazeli, Parastoo ;
Bolad, Waleed ;
Corretti, Mary ;
Magder, Laurence S. ;
Petri, Michelle .
RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) :2789-2796
[6]   Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade [J].
Bertsias, George K. ;
Salmon, Jane E. ;
Boumpas, Dimitrios T. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (09) :1603-1611
[7]   FLAXSEED - A POTENTIAL TREATMENT FOR LUPUS NEPHRITIS [J].
CLARK, WF ;
PARBTANI, A ;
HUFF, MW ;
SPANNER, E ;
DESALIS, H ;
CHINYEE, I ;
PHILBRICK, DJ ;
HOLUB, BJ .
KIDNEY INTERNATIONAL, 1995, 48 (02) :475-480
[8]   Dietary fish intake and sleep quality: a population-based study [J].
Del Brutto, Oscar H. ;
Mera, Robertino M. ;
Ha, Jung-eun ;
Gillman, Jennifer ;
Zambrano, Mauricio ;
Castillo, Pablo R. .
SLEEP MEDICINE, 2016, 17 :126-128
[9]  
Duffy EM, 2004, J RHEUMATOL, V31, P1551
[10]   Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis [J].
Elkan, A-C ;
Anania, C. ;
Gustafsson, T. ;
Jogestrand, T. ;
Hafstrom, I. ;
Frostegard, J. .
LUPUS, 2012, 21 (13) :1405-1411